The use of glucose in CD8+ RCC TIL activity after CD28 costimulation is consistent with other data in the field finding that phosphoenolpyruvate is necessary for maximal Ca/NFAT signaling to improve antitumor response (46). This evidence concerns the gene CD28 and renal cell carcinoma.